Alamar Biosciences, Inc.
Ticker: 2104204
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 33.55+14.0% | 29.43+13.0% | 26.04+30.8% | 19.91+23.2% | 16.16+23.5% | 13.09 |
| Total Income | 33.55+14.0% | 29.43+13.0% | 26.04+30.8% | 19.91+23.2% | 16.16+23.5% | 13.09 |
| EXPENSES | ||||||
| Expenditure | 48.68+13.3% | 42.96+11.9% | 38.38+38.1% | 27.80+15.4% | 24.08+11.3% | 21.64 |
| Tax | 0.09+200.0% | -0.09-119.6% | 0.46+4.5% | 0.44 | — | — |
| PROFIT | ||||||
| PBT | -13.25+0.3% | -13.29+36.3% | -20.86-175.9% | -7.56-7.7% | -7.02+8.4% | -7.66 |
| Net Profit | -13.34-1.1% | -13.20+38.1% | -21.33-166.6% | -8.00-14.0% | -7.02+8.4% | -7.66 |
| KEY METRICS | ||||||
| OPM % | -45.13%+0.85pp | -45.98%+1.44pp | -47.42%-7.83pp | -39.60%+9.40pp | -49.00%+16.34pp | -65.33% |
| NPM % | -39.77%+5.08pp | -44.85%+37.06pp | -81.91%-41.73pp | -40.18%+3.27pp | -43.45%+15.05pp | -58.51% |
| EPS | -0.19+13.6% | -0.22+87.4% | -1.74-152.2% | -0.69-11.3% | -0.62+8.8% | -0.68 |
Corporate Events
Board MeetingALMR
202631Dec
Board Meeting
Timothy "Tod" White will retire from his position as Preside…
SEC Filing ↗ Board MeetingALMR
20261Sep
Board Meeting
Robert Ragusa appointed to the Board of Directors and its co…
SEC Filing ↗